Takeda Pharmaceutical Co Ltd (SSE:4502)
円 4300 0 (0%) Market Cap: 6.48 Til Enterprise Value: 10.85 Til PE Ratio: 45.22 PB Ratio: 0.89 GF Score: 76/100

Takeda Pharmaceutical Co Ltd at Morgan Stanley Healthcare Conference Transcript

Sep 10, 2019 / 05:30PM GMT
Release Date Price: 円3760
Shinichiro Muraoka
Morgan Stanley, Research Division - Research Analyst

Okay. So let's get started with the session with Takeda. First of all, so I need to say for important disclosures, please see the Morgan Stanley research and disclosure website at www.morganstanley.com/researchdisclosures. So yes.

And today, we are with Dr. Andy Plump of -- Head of -- President of R&D of Takeda; and from IR team, Mr. Nobi Azuma-san is here. We need to say that, so -- of course, CFO, Mr. Costa Saroukos was planned to come join this session. However, probably some of you may know this. In Japan, a couple of days ago in the weekend, so very strong typhoon came. And due to that, so traffic was damaged significantly, so unfortunately, CFO, Mr. Costa, cannot join today. So from IR team, Nobi-san joined us.

So this is a good opportunity for talking about R&D. And in November, you plan to have an R&D Day, annual R&D Day and it's the first R&D Day after the integration. So I'd like to ask you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot